Ifp Advisors, Inc Spring Works Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 4,066 shares of SWTX stock, worth $147,026. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,066

Previous 2,788 45.84%

Holding current value

$147,026

Previous $137,000 11.68%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$36.06 - $47.62 $46,084 - $60,858	1,278 Added 45.84%	4,066 $153,000
Q1 2024 Jul 30, 2024	SELL	$36.5 - $52.5 $1,642 - $2,362	-45 Reduced 1.59%	2,788 $137,000
Q4 2023 Jan 09, 2024	SELL	$18.94 - $37.24 $454 - $893	-24 Reduced 0.84%	2,833 $103,000
Q3 2023 Oct 12, 2023	BUY	$23.12 - $31.38 $1,456 - $1,976	63 Added 2.25%	2,857 $66,000
Q2 2023 Aug 04, 2023	BUY	$23.15 - $32.71 $15,394 - $21,752	665 Added 31.24%	2,794 $73,000
Q1 2023 Apr 18, 2023	SELL	$24.97 - $34.05 $199 - $272	-8 Reduced 0.37%	2,129 $54,000
Q4 2022 Feb 07, 2023	BUY	$21.73 - $28.72 $347 - $459	16 Added 0.75%	2,137 $51,000
Q3 2022 Nov 08, 2022	BUY	$24.1 - $39.66 $1,662 - $2,736	69 Added 3.36%	2,121 $52,000
Q2 2022 Sep 06, 2022	BUY	$18.36 - $60.07 $37,674 - $123,263	2,052 New	2,052 $51,000
Q2 2022 Aug 12, 2022	SELL	$18.36 - $60.07 $37,674 - $123,263	-2,052 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$48.97 - $65.46 $13,074 - $17,477	267 Added 14.96%	2,052 $115,000
Q1 2022 Aug 08, 2022	BUY	$48.97 - $65.46 $1,028 - $1,374	21 Added 1.19%	1,785 $100,000
Q4 2021 Jan 12, 2022	BUY	$53.3 - $75.84 $41,733 - $59,382	783 Added 79.82%	1,764 $110,000
Q3 2021 Oct 06, 2021	BUY	$62.66 - $88.26 $61,469 - $86,583	981 New	981 $65,000

Others Institutions Holding SWTX

# of Institutions

240

Shares Held

68.9M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.26B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account